| Literature DB >> 25610467 |
Shamshul Ansari1, Hari Prasad Nepal1, Rajendra Gautam1, Sony Shrestha1, Puja Neopane1, Brihaspati Rimal2, Fuleshwar Mandal2, Safiur Rahman Ansari3, Moti Lal Chapagain1.
Abstract
Introduction. Children are among the most vulnerable population groups to contract illnesses. The varying microbiological pattern of septicemia warrants the need for an ongoing review of the causative organisms and their antimicrobial susceptibility pattern. Therefore, the objective of this study was to document the bacterial etiology of childhood septicemia and its antibiotic susceptibility profile. Methods. Cross-sectional type of study in 1630 suspected patients was conducted at CMCTH from January 2012 to December 2013. Blood samples were collected aseptically for culture. The organisms grown were identified by standard microbiological methods recommended by American Society for Microbiology (ASM) and subjected to antibiotic susceptibility testing by modified Kirby-Bauer disk diffusion method. Methicillin resistance was confirmed using cefoxitin and oxacillin disks methods. Results. Septicemia was detected in 172 (10.6%) cases. Among Gram-positive organisms, coagulase negative staphylococci (CoNS) were leading pathogen and Acinetobacter spp. were leading pathogen among Gram-negative isolates. Vancomycin, teicoplanin, and clindamycin were the most effective antibiotics against Gram-positive isolates while amikacin was effective against Gram-positive as well as Gram-negative isolates. Methicillin resistance was detected in 44.4% of Staphylococcus aureus. Conclusions. This study has highlighted the burden of bacterial etiology for septicemia among children in a tertiary care center of central Nepal.Entities:
Year: 2014 PMID: 25610467 PMCID: PMC4291139 DOI: 10.1155/2014/452648
Source DB: PubMed Journal: Int J Microbiol
Distribution of total and positive cases.
| Age | Total cases ( | Positive cases ( | |||
|---|---|---|---|---|---|
| Male | Female | Male | Female |
| |
| 1–11 months | 210 | 136 | 28 | 29 | 0.028 |
| 1–5 years | 295 | 187 | 26 | 22 | |
| 6–10 years | 269 | 144 | 18 | 15 | |
| 11–15 years | 242 | 147 | 22 | 12 | |
|
| |||||
| Total | 1016 (62.3%) | 614 (37.7%) | 94 (54.6%) | 78 (45.4%) | |
Distribution of bacterial isolates.
| Isolates | 1–11 months | 1–5 years | 6–10 years | 11–15 years | Total (%) |
|
|---|---|---|---|---|---|---|
| Gram-positive |
|
|
|
|
|
|
| Coagulase negative staphylococcus (CoNS) | 30 | 16 | 14 | 8 | 68 (39.5) | |
|
| 3 | 2 | 1 | 3 | 9 (5.2) | |
|
| 1 | 1 | 2 | 1 | 5 (3.0) | |
| Gram-negative |
|
|
|
|
| |
|
| 8 | 8 | 6 | 8 | 30 (17.5) | |
|
| 0 | 3 | 0 | 1 | 4 (2.3) | |
|
| 2 | 8 | 1 | 2 | 13 (7.6) | |
|
| 8 | 4 | 3 | 2 | 17 (9.9) | |
|
| 1 | 2 | 3 | 2 | 8 (4.6) | |
|
| 3 | 2 | 2 | 2 | 9 (5.2) | |
|
| 1 | 2 | 1 | 5 | 9 (5.2) | |
|
| ||||||
| Total (%) | 57 (33.1) | 48 (27.9) | 33 (19.2) | 34 (19.8) | 172 (100) | |
Antibiotic resistance profile of isolates.
| Isolated organisms | Rate of resistance to different antibiotics tested | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OX | FOX | VAN | TEI | E | CD | P | CFX | COT | G | AK | OF | CFM | CTX | CAZ | PI | PIT | CAR | AMX | NA | |
| Coagulase negative | 29.4 | 35.3 | 0 | 0 | 51.5 | 26.5 | 88.2 | 80.9 | 67.6 | 55.9 | 2.9 | 32.4 | X | X | X | X | X | X | X | X |
|
| 33.3 | 44.4 | 0 | 0 | 55.6 | 22.2 | 88.9 | 77.8 | 44.4 | 44.4 | 0 | 22.2 | X | X | X | X | X | X | X | X |
|
| 0 | X | 0 | 0 | 60.0 | 0 | 100 | X | X | 60.0 | 20.0 | 20.0 | X | X | X | X | X | X | X | X |
|
| X | X | X | X | X | X | X | X | 56.7 | 26.7 | 10.3 | 20.0 | 76.7 | 66.7 | 77.3 | 60.0 | 43.3 | X | 83.3 | X |
|
| X | X | X | X | X | X | X | X | X | 52.9 | 11.7 | 35.3 | 58.8 | 70.6 | 58.8 | 76.5 | 52.9 | 41.2 | 100 | X |
|
| X | X | X | X | X | X | X | X | 50.0 | 75.0 | 0 | 25.0 | 0 | 50.0 | 50.0 | 50.0 | 25.0 | X | 100 | X |
|
| X | X | X | X | X | X | X | X | 69.2 | 61.5 | 23.0 | 61.5 | 69.2 | 15.4 | 23.0 | 61.5 | 38.5 | X | 77.0 | X |
|
| X | X | X | X | X | X | X | X | 62.5 | 50.0 | 0 | 37.5 | 50.0 | 37.5 | 37.5 | 62.5 | 37.5 | X | 100 | X |
|
| X | X | X | X | X | X | X | X | 77.8 | 66.7 | 11.1 | 33.3 | 22.2 | 55.5 | 66.7 | 77.8 | 55.5 | X | 77.8 | X |
|
| X | X | X | X | X | X | X | X | 44.4 | 22.2 | 0 | 33.3 | 33.3 | 55.5 | 44.4 | 55.5 | 22.2 | X | 88.9 | 33.3 |
Note: OX: oxacillin, FOX: cefoxitin, VAN: vancomycin, TEI: teicoplanin, E: erythromycin, CD: clindamycin, P: penicillin G, CFX: cephalexin, COT: cotrimoxazole, G: gentamicin, AK: amikacin, OF: ofloxacin, CFM: cefixime, CTX: cefotaxime, CAZ: ceftazidime, PI: piperacillin, PIT: piperacillin-tazobactam, CAR: carbenicillin, AMX: amoxycillin, NA: nalidixic acid, X: not tested.